944146-30-9 Usage
Description
[1-(methoxymethyl)cyclopentyl]amine hydrochloride is a hydrochloride salt of [1-(methoxymethyl)cyclopentyl]amine, an organic compound with potential applications in the pharmaceutical industry. It is structurally related to amines and cyclopentyl compounds, and its chemical properties make it suitable for use as a building block in the synthesis of various pharmaceutical drugs and drug candidates. The hydrochloride salt form of the compound allows for better solubility and stability, making it easier to handle and formulate in drug preparations.
Used in Pharmaceutical Research and Drug Development:
[1-(methoxymethyl)cyclopentyl]amine hydrochloride is used as a building block for the synthesis of various pharmaceutical drugs and drug candidates due to its chemical properties and structural relation to amines and cyclopentyl compounds.
Used in Drug Preparations:
[1-(methoxymethyl)cyclopentyl]amine hydrochloride is used to improve solubility and stability in drug formulations, making it easier to handle and formulate in pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 944146-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,1,4 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 944146-30:
(8*9)+(7*4)+(6*4)+(5*1)+(4*4)+(3*6)+(2*3)+(1*0)=169
169 % 10 = 9
So 944146-30-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO.ClH/c1-9-6-7(8)4-2-3-5-7;/h2-6,8H2,1H3;1H
944146-30-9Relevant articles and documents
SUBSTITUTED HETEROCYCLIC COMPOUNDS
-
Page/Page column 90, (2010/10/03)
The present invention relates to substituted heterocyclic compounds of Formula I or XI: or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine II4 receptor inhibitors useful in the treatment of histamine II4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.
